About-cancer / ọgwụgwọ / ọgwụ / akpụkpọ

Ọgwụ akwadoro maka Ọrịa Skin

Peeji a depụtara ọgwụ cancer nke nri nri na ọgwụ ọjọọ (FDA) kwadoro maka ọrịa kansa anụ ahụ, gụnyere ọgwụ maka carcinoma basal cell, melanoma, na merkel cell carcinoma. Ndepụta ahụ gụnyere aha njirimara na aha njirimara. Aha ọgwụ na-ejikọta na nchịkọta NCI Cancer Information Information. Enwere ike ịnwe ọgwụ eji na kansa anụ ahụ edeghị ebe a.

N’IME Peeji a

• Ọgwụ akwadoro maka Basal Cell Carcinoma

• Ọgwụ akwadoro maka Mkpụrụ Mpempe Mpempe Cell Carcinoma

• Ọgwụ akwadoro maka Melanoma

• Ọgwụ akwadoro maka Merkel Cell Carcinoma

Ọgwụ akwadoro maka Basal Cell Carcinoma

Aldara (Imiquimod)

Efudex (Fluorouracil - Topical)

Erivedge (Vismodegib)

5-FU (Fluorouracil - Ndeba)

Fluorouracil - Nde

Imiquimod

Odomzo (Sonidegib)

Sonidegib

Vismodegib

Ọgwụ akwadoro maka Mkpụrụ Mpempe Mpempe Cell Carcinoma

Cemiplimab-rwlc

Libtayo (Cemiplimab-rwlc)

Ọgwụ akwadoro maka Melanoma

Aldesleukin

Cobimetinib

Cotellic (Cobimetinib)

Dabrafenib

Dacarbazine

DTIC-Dome (Dacarbazine)

IL-2 (Aldesleukin)

Imlygic (Nkọ Talimogene Laherparepvec)

Interleukin-2 (Aldesleukin)

Intron A (Ntughari Interferon Alfa-2b)

Ipilimumab

Keytruda (Pembrolizumab)

Onye na-akwado ya (Trametinib)

Nivolumab

Opdivo (Nivolumab)

Peginterferon Alfa-2b

Pembrolizumab

Proleukin (Aldesleukin)

Recombinant Interferon Alfa-2b

Sylatron (Peginterferon nke Alfa-2b)

Tafinlar (Dabrafenib)

Talimogene Laherparepvec

Trametinib

Vemurafenib

Jervoy (Ipilimumab)

Zelboraf (Vemurafenib)

Ọgwụ akwadoro maka Merkel Cell Carcinoma

Avelumab

Bavencio (Avelumab)

Keytruda (Pembrolizumab)

Pembrolizumab